Factors that Influence the Coverage of Vaccination against Pneumococcal Infections of Children up to 1 Year Old of Age at the Starting Phase of Vaccination

Whereas the quality of the program depends on promptness, full coverage, vaccination schedule abidance. Taking new Moscow regions as an example there have been studied factors influencing vaccination against Pneumococcal infection (PI). Insufficient provision of the vaccine to reach the desired level of coverage has been detected: in 2014 only 67.57% of liable children could receive double vaccination; the available quantity of vaccine in 2015 was able to provide 33. 84% of children up to 12 months old with double vaccination.However, the actual number of children vaccinated turned to be much lower (0.23% in 2014 and 20.85% in 2015).The survey of the doctors with the purpose of defining the level of knowledge and commitment to the vaccination against PI has shown a modest level of epidemiology, clinical implications, PIimmunoprophylaxis method awareness. Parental attitude towards PI vaccination has been estimated as positive. Parental interest to opportunities of immunoprophylaxis against PI is worthwhile noting despite the insufficient level of knowledgeability of its effects. Hence 74.5% of parents whose children are not vaccinated against PI would like to start vaccination, however a part of them look into receiving more information (29.41% parents).

пневмококковая инфекция, пневмококковая конъюгированная вакцина, охват вакцинацией, факторы, влияющие на вакцинацию, pneumococcal infection, pneumococcal conjugate vaccine, vaccination coverage, factors influencing vaccination

1. World Health Organization.Weekly epidemiological record. Pneumococcal vaccines. WHO position paper. 2012. Fact sheet No.14, 2012; 87: 129 – 144. Available at: http://www.who.int/wer

2. Koroleva I.S., Kharit S.M., Ruleva A.A., Perova A.L., Sidorenko S.V. Pneumococcal infection in Russia: epidemiological situation. Pediarticheskaya pharmokologia [Pediatric pharmacology]. 2010; 7 (4): 12 – 18 (in Russian).

3. The burden ofpneumococcalinfectionsandthe directions of improving epidemiological surveillance in Russia. Voprosi sovremennoi pediatrii [Current pediatrics]. 2009; 8 (2): 104-108 (in Russian).

4. Baranov A.A., Briko N.I., Namazova-Baranova L.S.,Ryapis L.A. Streptococci and pneumococci.Rostov-on-Don: Fenix; 2013 (in Russian).

5. Vaccinal Prevention of Pneumococcal Infection in Children. Edit.: Namazova-Baranova L.S. Moscow: Pediatrician; 2016(in Russian).

6. Sidorenko S.V., LobzinYu.V., Kharit S.M., Korolyova I.S., Tatochenko V.K. Pneumococcal infection and modern opportunities of its prophylaxis - epidemiological review of situation in the world and Russia. Voprosi sovremennoi pediatrii [Current pediatrics]. 2010; 9 (1): 162 – 69 (in Russian).

7. Afonso E.T., Minamisava R., Bierrenbach A.L., Escalante J.J.C., Alencar A.P., Domingues C.M. et al. Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil. EmergInfectDis. 2013; 4. Available at: http://wwwnc.cdc.gov/eid/article/19/4/12-1198_article

8. Romanenko V.V., Somova A.V., Kovtun O.V. The first lessons of a wide-scale pneumococcal infection vaccinal prevention program in the Sverdlovsk region. Pediarticheskaya pharmokologia [Pediatric pharmacology]. 2014; 11 (1): 86 – 90 (in Russian).

9. Ilyina S.V., Beletskaya O.A., Sabitov A.U., Chernaya N.L., Snegova N.F., Salkina O.A. et al. Theefficiency and safety of using pneumococcal conjugate vaccines in the Russian Federation: results of evaluation. Èpidemiologiâ I Infekcionnye Bolezni. Aktual’nye voprosy. [Epidemiology and Infection Diseases.Topical issues]. 2013; 6: 55 – 59 (in Russian).

10. Smith P.J., Nuorti J.P., Singleton J.A., Zhao Z., Wolter K.M. Effect of Vaccine Shortages on Timeliness of Pneumococcal Conjugate Vaccination: Results From the 2001 – 2005 National Immunization Survey. Pediatrics. 2007; 120 (5): e1165 – e73. Available at: http://pediatrics.aappublications.org/content/120/5/e1165.long

11. Saraiva F.O., Minamisava R., Vieira M.A., Bierrenbach A.L., Andrade A.L. Vaccination Coverage and Compliance with Three Recommended Schedules of 10-Valent Pneumococcal Conjugate Vaccine during the First Year of Its Introduction in Brazil: A Cross-Sectional Study. PLoSONE. 10 (6): e0128656. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128656.

12. Resolution of the meeting of the public coordination council on pneumococcal infection and vaccination in Russia. Epidemiologia i Vaccinoprofilaktika. [Epidemiology and Vaccinal Prevention]. 2016; 1: 43 – 47 (in Russian).

13. McIntosh D.G. International experience with 7-valent pneumococcal conjugate vaccine. Pediarticheskaya pharmokologia [Pediatric pharmacology]. 2009; 6 (2): 8 – 11 (in Russian).

14. Kostinov M.P. The new conjugate pneumococcal vaccine prevnar 13 - the effective protection of children against pneumococcal disease. Epidemiologia i Vaccinoprofilaktika. [Epidemiology and Vaccinal Prevention]. 2011; 6 (61): 99 – 107 (in Russian).

15. S hamsheva O.V., Uchaikin V.F., Medunitsyn N.V. Clinical vaccinology. Moscow: GEOTAR-Media; 2016 (in Russian).

16. Yasinsky A.A., Lytkina I.N., Mikheyeva I.V. On the issue of professional training of medical staff in the area of pediatric vaccine prophylaxis. Detskie infekcii. [Children Infections]. 2011; 10 (2): 35 – 39 (in Russian).

17. Epidemiologyand vaccinal prevention of pneumococcal infection. Methodical recommendations. MI 3.3.1.0027-11.2011 (in Russian).

18. Immunization with using pneumococcal polysaccharide vaccinefor the prevention of pneumococcal disease. Methodical recommendations. MI 3.3.1. 2008 (in Russian).

19. Letter of Ministry of Health of the Russian Federation from 08.06.2015 №24-2- 2031252 «By the use of pneumococcal polysaccharide conjugate adsorbed vaccine» Health Information Gazette Samara region. 2015; 27: 5 – 8 (in Russian).

20. Kostinov M.P., Chuchalin A.G., edit. Manual of Clinical Immunology in respiratory medicine. Moscow: ATMO; 2016 (in Russian).

21. Zverev V.V., Semenov B.F., Khaitov R.M., edit. Vaccines and vaccination. National manual. Moscow: GEOTAR-Media; 2011 (in Russian).

22. Kostinov M.P., Pahomov D.V. Efficacy and Safety of the Vaccine Prevenar in Children and Adults at Risk. Epidemiologia i Vaccinoprofilaktika. [Epidemiology and Vaccinal Prevention]. 2010; 3 (52): 68 – 71 (in Russian).